These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22900055)

  • 101. Do Polymorphisms of the TERT, GSTM1, and GSTT1 Genes Increase Laryngeal Cancer Susceptibility in Smokers of Romanian Descent?
    Cornean CI; Catana A; Maniu AA
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013573
    [No Abstract]   [Full Text] [Related]  

  • 102. Genotype of Null Polymorphisms in Genes GSTM1, GSTT1, CYP1A1, and CYP1A1*2A (rs4646903 T>C)/CYP1A1*2C (rs1048943 A>G) in Patients with Larynx Cancer in Southeast Spain.
    Sánchez-Siles M; Pelegrín-Hernández JP; Hellin-Meseguer D; Guerrero-Sánchez Y; Corno-Caparrós A; Cabezas-Herrera J; Pastor-Quirante F; Fernández-Ruiz JA; Aliaga-Sánchez A; Lucero-Berdugo M; Camacho-Alonso F
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32882964
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.
    Alfarouk KO; Stock CM; Taylor S; Walsh M; Muddathir AK; Verduzco D; Bashir AH; Mohammed OY; Elhassan GO; Harguindey S; Reshkin SJ; Ibrahim ME; Rauch C
    Cancer Cell Int; 2015; 15():71. PubMed ID: 26180516
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis.
    Li Q; Liu M
    Tumour Biol; 2014 Sep; 35(9):8781-5. PubMed ID: 24879623
    [TBL] [Abstract][Full Text] [Related]  

  • 105. GSTM1 null polymorphisms is associated with laryngeal cancer risk: a meta-analysis.
    Zhang Y; Chen W; Ji JF; Wang ZY; Wu MH; Zhang K; Wang QP
    Tumour Biol; 2014 Jul; 35(7):6303-9. PubMed ID: 24643684
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Association of the glutathione s-transferase m1, t1 polymorphisms with cancer: evidence from a meta-analysis.
    Fang J; Wang S; Zhang S; Su S; Song Z; Deng Y; Cui H; Wang H; Zhang Y; Qian J; Gu J; Liu B; Li P; Zhang R; Liu X; Wang Z
    PLoS One; 2013; 8(11):e78707. PubMed ID: 24250808
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Glutathione S-transferase M1 polymorphism and coronary heart disease susceptibility: a meta-analysis involving 47,596 subjects.
    Zhou D; Hu W; Wang Q; Jin Y
    Heart Lung Circ; 2014 Jun; 23(6):578-85. PubMed ID: 24525147
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Glutathione S-transferase M1 gene polymorphism and laryngeal cancer risk: a meta-analysis.
    Ying XJ; Dong P; Shen B; Xu CZ; Xu HM; Zhao SW
    PLoS One; 2012; 7(8):e42826. PubMed ID: 22900055
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Quantitative assessment of the association between GSTM1 null genotype and laryngeal cancer risk.
    Xiao H; Li M; Tian L; Zha B; Liu M; Yao H
    Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):615-22. PubMed ID: 22972496
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Lack of association between glutathione S-transferase T1 gene polymorphism and laryngeal cancer susceptibility: a meta-analysis based on 2,124 cases and 2,059 controls.
    Ying XJ; Xu CZ; Xu HM; Sun ZF; Zhang J; Wang GL; Dong P
    Gene; 2012 Feb; 494(1):11-6. PubMed ID: 22207034
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Glutathione S-transferase M1 and T1 status and the risk of laryngeal cancer: a meta-analysis.
    Kumar V; Murthy AK; Suresh KP
    Asian Pac J Cancer Prev; 2011; 12(9):2221-6. PubMed ID: 22296360
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    Open Med; 2009; 3(3):e123-30. PubMed ID: 21603045
    [No Abstract]   [Full Text] [Related]  

  • 113. GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population.
    Chatzimichalis M; Xenellis J; Tzagaroulakis A; Sarof P; Banis K; Gazouli M; Bibas A
    J Laryngol Otol; 2010 Mar; 124(3):318-23. PubMed ID: 19922706
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses.
    Zhuo WL; Wang Y; Zhuo XL; Zhu B; Zhu Y; Chen ZT
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1081-90. PubMed ID: 19252926
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis.
    Carlsten C; Sagoo GS; Frodsham AJ; Burke W; Higgins JP
    Am J Epidemiol; 2008 Apr; 167(7):759-74. PubMed ID: 18270371
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.